James Daly

Mr. James M.
Daly is an Independent Director at Madrigal Pharmaceuticals, Inc., an Independent Non-Executive Director at argenx SE and an Independent Director at ACADIA Pharmaceuticals, Inc. He is on the Board of Directors at Madrigal Pharmaceuticals, Inc., argenx SE and ACADIA Pharmaceuticals, Inc. Mr. Daly was previously employed as an Independent Director by Bellicum Pharmaceuticals, Inc., an Independent Director by Halozyme Therapeutics, Inc., an Independent Director by Chimerix, Inc., a Chief Commercial Officer & Executive VP by Incyte Corp., a Senior Vice President by Amgen Ventures LLC, a SVP-Global Marketing & Commercial Development by Amgen, Inc., a Senior Vice President-Respiratory Division by Smithkline Beecham Corp., and a Principal by Francis Cauffman, Inc. He also served on the board at Coherus BioSciences, Inc. He received his undergraduate degree from State University of New York at Buffalo and an MBA from State University of New York at Buffalo.